http://www.zibb.com/all/theme/cq/Generex+Biotechnology+Corporation Zibb. The Global business search engine. en-US search@zibb.com (RB Search)Copyright (c) 2007 Reed Business Information. All rights reserved.Thu, 26 Nov 2009 19:24:58 GMTThu, 26 Nov 2009 19:24:58 GMT608831http://www.zibb.com/all/theme/cq/Generex+Biotechnology+Corporation http://www.zibb.com/images/en/g_zibb_logo_beta.gif http://www.generex.com/forums/profile.php?mode=register&agreed=true&sid=b4b3498a0d216cfae3bd629a1da600b5If you are visually impaired or cannot otherwise read this code please contact the Administrator for help.http://www.generex.com/forums/profile.php?mode=register&agreed=true&sid=b4b3498a0d216cfae3bd629a1da600b5Generex Biotechnology Corporationhttp://www.cbronline.com/companyprofile.asp?guid=E86C936A-D2BF-4B85-B04F-DCD998371ACC&alpha=gFor the fiscal year ended July 2004, Generex Biotechnology generated revenues of $0.6 million. The company saw a net loss of $18.4 million during fiscal 2004, an increase of 38.3% on fiscal 2003.http://www.cbronline.com/companyprofile.asp?guid=E86C936A-D2BF-4B85-B04F-DCD998371ACC&alpha=gGenerex Biotechnology Corporationhttp://www.biz-lib.com/ZEB67482.htmlGenerex Biotechnology Corporation is developing new methods for the delivery of large-molecule drugs. Generex' proprietary RapidMist device administers medications directly into the mouth as a metered-dose spray, for rapid absorption by the buccal mucosa.http://www.biz-lib.com/ZEB67482.htmlGenerex Biotechnology Corporationhttp://www.newsrx.com/article.php?articleID=4877722007 MAR 5 -- Generex Biotechnology Corporation (NasdaqCM:GNBT - News) announced today that its wholly owned subsidiary, Antigen Express, Inc., has received a Notice of Allowance in connection with US Patent Application No. 10/197,000 entitled Hybrid Peptides Modulate the Immune Response.http://www.newsrx.com/article.php?articleID=487772Generex Biotechnology Corporationhttp://www.quotelinks.com/companies/gnbt.htmlStock quotes, news and charts for Generex Biotechnology Corporation Quotes Simple Charts Stock News MSN Investor Thomson Investors Short Interest Yahoo Finance CBS Marketwatch BigCharts StockCharts.com Yahoo Lycos Investing Quicken Yahoo News Quote.com (Lycos) CNET news ZDNet Business Week Stockhttp://www.quotelinks.com/companies/gnbt.htmlGenerex Biotechnology Corporationhttp://www.pharmacychoice.com/News/article.cfm?Article_ID=14101. Dr. Guevara-Aguirre made an oral presentation of an abstract entitled "Addition of Oral-lyn(TM) at Mealtimes in Subjects with Type-2 Diabetes Maintained on Glargine + Metformin - A Comparison with Placebo".http://www.pharmacychoice.com/News/article.cfm?Article_ID=14101Generex Biotechnology Corporationhttp://www.computerbusinessreview.com/companyprofile.asp?guid=E86C936A-D2BF-4B85-B04F-DCD998371ACC&CType=Locations** NEW FEATURE ** Sign-up for NewsAlerts on Generex Biotechnology so that whenever news breaks on this company you are amongst the first to know. Click here...http://www.computerbusinessreview.com/companyprofile.asp?guid=E86C936A-D2BF-4B85-B04F-DCD998371ACC&CType=LocationsGenerex Biotechnology Corporationhttp://www.thelabrat.com/jobs/companies/Generex.shtmlGenerex Biotechnology Corporation is a drug delivery company that has developed a proprietary technology to orally administer large molecule drugs. These drugs include proteins, peptides, monoclonal antibodies, hormones and vaccines.http://www.thelabrat.com/jobs/companies/Generex.shtmlGenerex Biotechnology Corporationhttp://www.biospace.com/news_story.aspx?StoryID=52069&full=1TORONTO -- (MARKET WIRE) -- April 11, 2007 -- Generex Biotechnology Corporation (NASDAQ: GNBT) announced today that it will be making two poster presentations at the American Association of Clinical Endocrinologists (AACE) 16th Annual Meeting & Clinical Congress (www.aace.http://www.biospace.com/news_story.aspx?StoryID=52069&full=1Generex Biotechnology Corporationhttp://www.micromedex.com/pressroom/news_feeds/?story_ID=108920&category=1Get the news that matters to you. Create your own customized news service that delivers the latest information directly to you. Plus you can view the most current press releases from Micromedex.http://www.micromedex.com/pressroom/news_feeds/?story_ID=108920&category=1Generex Biotechnology Corporationhttp://www.buyandhold.com/StockMgr?request=display.content&symbol=GNBT&ContentURL=%2Fcustom%2Fbuyandhold%2Dcom%2Fhtml%2Dnews%2Easp&symb=GNBTCopyright © 2006 MarketWatch, Inc. All rights reserved. Please see our Terms of Use. MarketWatch, the MarketWatch logo, and BigCharts are registered trademarks of MarketWatch, Inc. Intraday data provided by ComStock, an Interactive Data Company and subject to the Terms of Use.http://www.buyandhold.com/StockMgr?request=display.content&symbol=GNBT&ContentURL=%2Fcustom%2Fbuyandhold%2Dcom%2Fhtml%2Dnews%2Easp&symb=GNBTGenerex Biotechnology Corporationhttp://www.generex.com/forums/profile.php?mode=sendpassword&sid=2e68b9211809b3d0e6e02f02fa244d81Generex Biotechnology Corporation Forum Index Generex Biotechnology Corporation The leader in drug delivery for metabolic diseases through the inner lining of the mouth FAQ FAQ Search Search Memberlist Memberlist Usergroups Usergroups Register Register Profile Profile Log in to check your privatehttp://www.generex.com/forums/profile.php?mode=sendpassword&sid=2e68b9211809b3d0e6e02f02fa244d81Generex Biotechnology Corporationhttp://www.generex.com/forums/profile.php?mode=register&sid=d81ac20491b215650eaf31471b817f1aWhile the administrators and moderators of this forum will attempt to remove or edit any generally objectionable material as quickly as possible, it is impossible to review every message.http://www.generex.com/forums/profile.php?mode=register&sid=d81ac20491b215650eaf31471b817f1aGenerex Biotechnology Corporationhttp://www.pharmacychoice.com/News/article.cfm?Article_ID=571472007 MAY 23 - (NewsRx.com) -- Generex Biotechnology Corporation (NasdaqCM:GNBT - News) announced today that the first patients have been treated in a Phase II clinical trial of its novel immunotherapeutic vaccine AE37 being developed by Generex's wholly owned Antigen Express subsidiary.http://www.pharmacychoice.com/News/article.cfm?Article_ID=57147Generex Biotechnology Corporationhttp://www.pharmacychoice.com/News/article.cfm?Article_ID=27800The Bellwether Report Takes Notice of Generex Biotechnology Corp. (Nasdaq:GNBT) Generex Biotechnology knows that needles can be a real pain for diabetics, so the firm created the RapidMist drug delivery system that mists its Oral-lyn insulin into their mouth, where it is absorbed.http://www.pharmacychoice.com/News/article.cfm?Article_ID=27800Generex Biotechnology Corporationhttp://www.pharmacychoice.com/News/article.cfm?Article_ID=10347Oral-lyn(TM) has been approved for commercial marketing and sale by the Ecuadorian Ministry of Public Health for the treatment of both Type-1 and Type-2 diabetes. The Company, together with its South American joint venture partner PharmaBrand, S.A. (www.pharmabrand.com.http://www.pharmacychoice.com/News/article.cfm?Article_ID=10347Generex Biotechnology Corporation